Global Corneal Transplant Market Set for Expansive Growth during the forecast period
Market Highlights
Corneal transplant is a surgical procedure performed for the treatment
of diseased cornea. Important indications for corneal transplant are
keratoconus, keratitis, and corneal stromal dystrophies. The success rate of
the treatment is found to be high, which support the market growth.
Rising prevalence of vision impartment and eye diseases such as diabetic
retinopathy in geriatric population and diabetes across the globe drive the
global market. Additionally, rising awareness about organ donation and its
importance, especially, in the developing countries likely to propel the market
growth.
Access Report Details @ https://www.marketresearchfuture.com/reports/corneal-transplant-market-4525
Cost of corneal transplant varies depending upon the region,
availability of services, and skilled and qualified professionals. Major
difference in the cost is observed, i.e. it is found to be high in the
developed countries and low in developing countries still maintaining
qualitative care. Therefore, cost effective of the treatment would affect the
market growth.
The global corneal transplant market share is expected to grow at a CAGR
of 10.8% during the forecast period.
Major Players in Corneal transplant market share:
Some of the key players in the global market are CryoLife, Inc. (U.S.),
Exactech, Inc. (U.S.), Köhler GmbH (U.S.), Lifeline Scientific (U.S), LifeCell
Corporation (U.S.), Medtronic (U.S.), and Organogenesis Inc. (U.S.).
Regional Analysis
Europe is the largest market for corneal transplant which will exhibit
positive growth in the near future due to rising prevalence of diabetes in the
European countries and availability of treatment options. According to the
World Health Organization, about 60 million Europeans have diabetes and its
prevalence is relatively high among people over 25 years.
America is the second leading corneal transplant market share across the globe owing to an increasing demand for corneal transplant
surgery, and rising prevalence of eye diseases, and vision impairment among
people in the U.S.
Asia Pacific market is expected to grow rapidly owing increasing
prevalence of chronic diseases such as diabetes, diabetic retinopathy, and
obesity. India is one of the international medical tourism destinations across
the world, which further exhibits growth opportunities for the corneal
transplant market share due to availability of cost-effective treatment and
rising success rates. Furthermore, the increasing healthcare expenditure
by developing countries in Asia Pacific region also contributes to the market growth.
The Middle East & African market is growing steadily owing to rising
demand for ophthalmic products and services, and available treatment options.
Segmentation
The global corneal transplant market share is segmented on the basis of
type, indication, and end user.
On the basis of type, the market is segmented into penetrating
keratoplasty, endothelial keratoplasty, descemet stripping automated
endothelial keratoplasty (DSAEK), corneal graft, corneal limbal stem cell
transplant, and others.
On the basis of indication, the market is segmented into fungal corneal
ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal
dystrophies, and others.
On the basis of end user, the market is segmented into hospitals, eye
clinics, and others.
Request a Sample Report @
https://www.marketresearchfuture.com/sample_request/4525
NOTE: Our Team of Researchers
are Studying Covid19 and its Impact on Various Industry Verticals and wherever
required we will be considering Covid19 Footprints for Better Analysis of
Market and Industries. Cordially get in Touch for More Details.
Comments
Post a Comment